Cor Vasa 2011, 53(6-7):328-332 | DOI: 10.33678/cor.2011.082
The effect of a biocompatible coated cardiopulmonary bypass system on fibrinogen levels as determined by the TEG Functional Fibrinogen method - preliminary results
- 1 Kardiochirurgická klinika, Fakultní nemocnice Olomouc a Lékařská fakulta Univerzity Palackého, Olomouc
- 2 Ústav lékařské biofyziky, Lékařská fakulta Univerzity Palackého, Olomouc, Česká republika
When cardiopulmonary bypass (CPB) is used, the blood comes into contact with foreign surfaces. It causes an activation of numerous cascade and cell systems, including coagulation. To diminish this impact, various types of biocompatible coated surfaces have been developed. We studied the effect of heparin-coated CPB systems on the level and function of fibrinogen as measured by TEG, compared with non-coated systems. No statistically significant differences between both groups were revealed by comparing paired data.
Keywords: Biocompatible surface; Functional fibrinogen; TEG; Coagulation; Cardiopulmonary bypass
Published: June 1, 2011 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Deptula J, Glogowski K, Merrigan K, et al. Evaluation of biocompatible cardiopulmonary bypass circuit use during pediatric open heart surgery. J Extra Corpor Technol 2006;38:22-26.
Go to original source...
Go to PubMed...
- Koh SC, Chew CY, Viegas OA, et al. Influence of circulating D-dimer levels on assays of fibrinogen. Ann Acad Med Singapore 1994;23:856-860
- Gunaydin S, McCusker K, Vijay V, et al. Comparison of polymethoxyethylacrylate-coated circuits with leukocyte filtration and reduced heparinization protocol on heparin-bonded circuits in different risk cohorts. Perfusion 2006;21:329-342.
Go to original source...
Go to PubMed...
- Deptula J, Glogowski K, Merrigan K, et al. Evaluation of biocompatible cardiopulmonary bypass circuit use during pediatric open heart surgery. J Extra Corpor Technol 2006;38:22-26.
Go to original source...
Go to PubMed...
- Carroll R.C., Craft R.M., Chavez J., et al. Measurement of functional fibrinogen levels using the thrombelastograph. J Clinic Anesth 2008;20:186-190.
Go to original source...
Go to PubMed...
- Pappalardo F, Della Valle P, Crescenzi G, et al. Phosphorylcholine coating may limit thrombin formation during high-risk cardiac surgery: a randomized controlled trial. Ann Thorac Surg 2006;81:886-691.
Go to original source...
Go to PubMed...
- Borowiec J, Thelin S, Bagge L, et al. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1992;104:642-647.
Go to original source...
- Fosse E, Moen O, Johnson E, et al. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1994;58:472-477.
Go to original source...
Go to PubMed...
- Jameel S, Colah S, Klein A. Recent advances in cardiopulmonary bypass techniques. Cont Educ Anaesth Crit Care Pain 2010;10:20-23.
Go to original source...
- Wagner WR, Johnson PC, Thompson KA, Marrone GC. Heparin coated cardiopulmonary bypass circuits: hemostatic alteration and postoperative blood loss. Ann Thorac Surg 1994;58:734-740.
Go to original source...
Go to PubMed...
- Gorman RC, Ziats NP, Rao AK, et al. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996;111:1-12.
Go to original source...
Go to PubMed...
- Ranucci M., Balduini A., Ditta A., et al. A systematic review of biocompatible cardiopulmonary bypass circuits and clinical outcome. Ann Thorac Surg 2009;87:1311-1319.
Go to original source...
Go to PubMed...
- Mangoush O, Purkayastha S, Haj-Yahia S, et al. Heparin-bounded circuits versus nonheparin-bounded circuits: an evaluation of their effect on clinical outcomes. Eur J Cardiothorac Surg 2007;31:1058-1069.
Go to original source...
Go to PubMed...